Literature DB >> 19213494

[Ocular manifestations of diabetes: 285 cases].

Imen Zghal-Mokni1, Leila Nacef, Imène Letaief, Sonia Mahjoub, Hédi Bouguila, Samira Blouza, Amel Jeddi, Saïda Ayed.   

Abstract

BACKGROUND: Diabetes is one of the principal cause of blindness in adults. The aim of the study is to evaluate the frequency of ocular complications and risk factors of diabetes. It's a multicentric prospective study on a representative sample of 285 diabetics.
METHODS: We performed a general and an ophthalmologic exam for all patients with retinal angiography and appropriate laboratory tests. Chi 2, Fisher, Mann and Whitney tests were used as statistical methods.
RESULTS: Diabetic retinopathy was observed in 45,2% of patients, cataract in 22%, glaucoma in 5%. Diabetic retinopathy frequency rises especially with duration of diabetes and bad glycaemic control. Blindness related to diabetic retinopathy was observed in 6,25% and visual deficiency in 12,5%. The authors compared their results with literature data. They emphasize on the great value of regular better glycaemic control and other associated metabolic disorders.
CONCLUSION: We concluded that a regular ophthalmologic follow up is necessary for early diabetic retinopathy detection and treatment.

Entities:  

Mesh:

Year:  2008        PMID: 19213494

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  3 in total

1.  Prevalence and causes of visual impairment in diabetic patients in Tunisia, North Africa.

Authors:  R Kahloun; B Jelliti; S Zaouali; S Attia; S Ben Yahia; S Resnikoff; M Khairallah
Journal:  Eye (Lond)       Date:  2014-06-13       Impact factor: 3.775

2.  The anterior segment of the eye in diabetes.

Authors:  Co Adeoti; Ma Isawumi; Ao Ashaye; Bv Olomola
Journal:  Clin Ophthalmol       Date:  2012-05-07

3.  Intake of Gnetum africanum and Dacryodes edulis, imbalance of oxidant/antioxidant status and prevalence of diabetic retinopathy in central Africans.

Authors:  Mvitu-Muaka Moise; Longo-Mbenza Benjamin; Mokondjimobe Etienne; Gombet Thierry; Kibokela Ndembe Dalida; Tulomba Mona Doris; Wayiza Masamba Samy
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.